NeuroAiD™II awarded Gold accreditation by
independent nonprofit Empowered By Evidence (EBE)
Bringing Innovative Solutions to Healthcare Practitioners
Bringing Innovative Solutions to Healthcare Practitioners.
A Focus on Neurology
Since Moleac was founded, our ambition is to provide new solutions to supplement the therapeutic armamentarium for conditions where significant unmet needs remain. To achieve this goal, we develop natural products according to international standards and commercialize our products worldwide.
Our products are developed by Moleac with scientific excellence and evidence-based approach.
Together with our R&D department and world renowned experts, we have successfully developed and marketed NeuroAiD, the world’s first post-stroke recovery treatment, helping patients to regain functional independence after a stroke or a traumatic brain injury by amplifying endogenous processes of brain repair. NeuroAiD is available in over 30 countries worldwide.
Challenging the Boundaries Of The Possible.
OUR INNOVATION TO RECONNECT AFTER A BRAIN INJURY
NeuroAiD is an oral treatment helping patients of brain and spinal cord injuries who suffer from established deficits to recover their functional independence in addition to rehabilitation therapy and exercises. NeuroAiD also supports cognitive functions in Alzheimer’s Disease.
Patients taking NeuroAid yearly
Awards
Countries with Exclusive Partnership
Shaping the Future of Neurological Care
Latest News
Can a Healthy Diet Delay Dementia? New Evidence in Older Adults With Alzheimer’s Pathology
📰🧠🔬 DEMENTIA STUDY HIGHLIGHTS – Diet Quality and Dementia Risk in Older Adults With Alzheimer Pathology by Mrhar A., et al.
Highlights from Moleac’s AAIC 2026 Symposium on Alzheimer’s Disease
Last night, Moleac hosted a symposium on The Role of NeuroAiD in the Management of Alzheimer’s Disease.
Visit Moleac Today at AAIC 2026 – Booth #1030
Moleac is attending the Alzheimer’s Association International Conference (AAIC) 2026 in London, UK, from July 12–15.
Meet Moleac at AAIC 2026: Advancing Alzheimer’s Disease Care Together
Moleac is attending the Alzheimer’s Association International Conference (AAIC) 2026 in London, UK (July 12–15).
Meet Moleac at AAIC 2026 in London – Visit Us at Booth #1030
Moleac will be attending the Alzheimer’s Association International Conference (AAIC) 2026 in London, UK (July 12–15).
Advancing Brain Injury Care: Highlights from Labuan Bajo, Indonesia
How Telemedicine Is Transforming Global Neurosurgical Care: Insights from a New Scoping Review
Thank You for Joining Moleac’s AACNS 2026 Lunch Symposium
Thank you for joining us at the Moleac Lunch Symposium at AACNS in Manila.
Meet the Moleac Team at AACNS 2026 – Visit Us at Booth #28
Our team is at the 18ᵗʰ Asian Australasian Congress of Neurological Surgeons (AACNS) in Manila!
Advancing Alzheimer’s Disease Care Through Scientific Collaboration in Türkiye
Advancing the management of Alzheimer’s disease through scientific collaboration.
